Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in cervical cancer

Virology Journal

Volumn 10, Issue , 2013, Pages

  Yao, Tingting ^a   Rao, Qunxian ^a   Liu, Longyang ^a   Zheng, Chengyu ^a   Xie, Qingsheng ^a   Liang, Jinxiao ^a   Lin, Zhongqiu ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cervical cancer; Hypermethylation; miRNA

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CISPLATIN; FLUOROURACIL; MICRORNA; MICRORNA 1286; MICRORNA 1287; MICRORNA 1290; MICRORNA 432; MICRORNA 95; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; DNA METHYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UTERINE CERVIX CANCER;

AZACITIDINE; CELL LINE, TUMOR; DNA METHYLATION; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION PROFILING; GENE SILENCING; HUMANS; MICROARRAY ANALYSIS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 84878376565     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-175     Document Type: Article

References (27)

1. Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination. Schache AG, Liloglou T, Risk JM, Filia A, Jones TM, Sheard J, Woolgar JA, Helliwell TR, Triantafyllou A, Robinson M, Sloan P, Harvey-Woodworth C, Sisson D, Shaw RJ, Clin Cancer Res 2011 17 6262 6271 10.1158/1078-0432.CCR- 11-0388 21969383
2. HPV analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. Bishop JA, Ogawa T, Chang X, Illei PB, Gabrielson E, Pai SI, Westra WH, Am J Surg Pathol 2012 36 142 148 10.1097/PAS.0b013e3182395c7b 22173119
3. Prevalence of human papillomavirus 16/18/33 infection and p53 mutation in lung adenocarcinoma. Iwakawa R, Kohno T, Enari M, Kiyono T, Yokota J, Cancer Sci 2010 101 1891 1896 10.1111/j.1349-7006.2010.01622.x 20557307
4. Human papillomavirus infection in oral papillary and verrucous lesions is a prognostic indicator of malignant transformation. Hwang CF, Huang CC, Chien CY, Huang SC, Yang CH, Su CY, Cancer Epidemiol 2012 36 122 e127 10.1016/j.canep.2011.10.006 22104545
5. Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche Linear Array HPV genotyping assay. Liu SS, Leung RC, Chan KK, Cheung AN, Ngan HY, J Clin Microbiol 2010 48 758 764 10.1128/JCM.00989-09 20042614
6. Significance analysis of microarrays applied to the ionizing radiation response. Tusher VG, Tibshirani R, Chu G, Proc Natl Acad Sci USA 2001 98 5116 5121 10.1073/pnas.091062498 11309499 (Pubitemid 32397092)
7. Quantitative detection of multiple gene promoter hypermethylation in tumor tissue, serum, and cerebrospinal fluid predicts prognosis of malignant gliomas. Liu BL, Cheng JX, Zhang W, Zhang X, Wang R, Lin H, Huo JL, Cheng H, Neuro Oncol 2010 12 540 548 10.1093/neuonc/nop064 20154338
8. Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells. Zhang Y, Chen FQ, Sun YH, Zhou SY, Li TY, Chen R, J Exp Clin Cancer Res 2011 30 98 10.1186/1756-9966-30-98 21999220
9. Let-7a regulation of insulin-like growth factors in breast cancer. Lu L, Katsaros D, Zhu Y, Hoffman A, Luca S, Marion CE, Mu L, Risch H, Yu H, Breast Cancer Res Treat 2011 126 687 694 10.1007/s10549-010-1168-5 20848182
10. MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20. Yao T, Lin Z, Biochim Biophys Acta 2012 1822 248 260 10.1016/j.bbadis. 2011.09.018 22001440
11. 5-Aza-2' deoxycytidine may influence proliferation and apoptosis of cervical cancer cell by methylation in a dose- and time-dependent way. Yao TT, Mo SM, Liu LY, Lu HW, Huang ML, Lin ZQ, Genet Mol Res 2013 12 312 318 10.4238/2013.February.4.5 23408418
12. Identification of postoperative prognostic microRNA predictors in hepatocellular carcinoma. Huang YH, Lin KH, Chen HC, Chang ML, Hsu CW, Lai MW, Chen TC, Lee WC, Tseng YH, Yeh CT, PLoS One 2012 7 37188 10.1371/journal.pone. 0037188 22629365
13. Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1. D'Angelo D, Palmieri D, Mussnich P, Roche M, Wierinckx A, Raverot G, Fedele M, Croce CM, Trouillas J, Fusco A, J Clin Endocrinol Metab 2012 97 1128 E1138 10.1210/jc.2011-3482 22564666
14. Chemotherapy-induced modification of microRNA expression in esophageal cancer. Hummel R, Wang T, Watson DI, Michael MZ, Van der Hoek M, Haier J, Hussey DJ, Oncol Rep 2011 26 1011 1017 21743970
15. Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes. Díaz-Prado S, Cicione C, Muiños-López E, Hermida-Gómez T, Oreiro N, Fernández-López C, Blanco FJ, BMC Musculoskelet Disord 2012 13 144 10.1186/1471-2474-13-144 22883423
16. Comprehensive analysis of alterations in the miRNome in response to photodynamic treatment. Bach D, Fuereder J, Karbiener M, Scheideler M, Ress AL, Neureiter D, Kemmerling R, Dietze O, Wiederstein M, Berr F, Plaetzer K, Kiesslich T, Pichler M, J Photochem Photobiol B 2013 120 74 81 23466801
17. Up-regulation of microRNA-1290 impairs cytokinesis and affects the reprogramming of colon cancer cells. Wu J, Ji X, Zhu L, Jiang Q, Wen Z, Xu S, Shao W, Cai J, Du Q, Zhu Y, Mao J, Cancer Lett 2013 329 155 163 10.1016/j.canlet.2012.10.038 23142292
18. Genome-wide screen for aberrantly expressed miRNAs reveals miRNA profile signature in breast cancer. Guo L, Zhao Y, Yang S, Cai M, Wu Q, Chen F, Mol Biol Rep 2012
19. MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response. Wang W, Corrigan-Cummins M, Hudson J, Maric I, Simakova O, Neelapu SS, Kwak LW, Janik JE, Gause B, Jaffe ES, Calvo KR, Haematologica 2012 97 586 94 10.3324/haematol.2011.048132 22102710
20. High dose glargine alters the expression profiles of microRNAs in pancreatic cancer cells. Li WG, Yuan YZ, Qiao MM, Zhang YP, World J Gastroenterol 2012 18 2630 2639 10.3748/wjg.v18.i21.2630 22690071
21. MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma. Huang Z, Huang S, Wang Q, Liang L, Ni S, Wang L, Sheng W, He X, Du X, Cancer Res 2011 71 2582 2589 10.1158/0008-5472.CAN-10-3032 21427358
22. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. Zhang Y, Li M, Wang H, Fisher WE, Lin PH, Yao Q, Chen C, World J Surg 2009 33 698 709 10.1007/s00268-008-9833-0 19030927
23. Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers. Nurul-Syakima AM, Yoke-Kqueen C, Sabariah AR, Shiran MS, Singh A, Learn-Han L, Int J Mol Med 2011 28 327 336 21637912
24. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Cheng AM, Byrom MW, Shelton J, Ford LP, Nucleic Acids Res 2005 33 1290 1297 10.1093/nar/gki200 15741182 (Pubitemid 41439922)
25. Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK. Wang M, Li C, Nie H, Lv X, Qu Y, Yu B, Su L, Li J, Chen X, Ju J, Yu Y, Yan M, Gu Q, Zhu Z, Liu B, FEBS Lett 2012 586 2382 2388 10.1016/j.febslet.2012.05.050 22677169
26. Identification of differentially expressed microRNAs in endometrial cancer cells after progesterone treatment. Bae J, Won M, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH, Suh DS, Int J Gynecol Cancer 2012 22 561 565 10.1097/IGC.0b013e31824927db 22543862
27. MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma. Zhang Z, Tang H, Wang Z, Zhang B, Liu W, Lu H, Xiao L, Liu X, Wang R, Li X, Wu M, Li G, Mol Cancer 2011 10 124 124 10.1186/1476-4598-10-124 21962230